|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"yen c j"
Showing items 181-230 of 471 (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2021-01-14T06:25:59Z |
Seroprevalence of hepatitis B viral markers among freshmen - 20 years after mass hepatitis B vaccination program in Taiwan
|
Chang H.-C.; Yen C.-J.; Lee Y.-C.; Chiu T.-Y.; CHYI-FENG JAN |
| 臺大學術典藏 |
2021-01-12T03:32:35Z |
Age-associated changes in interferon-γ and interleukin-4 secretion by purified human CD4+ and CD8+ T cells
|
Yen C.-J.;Shuei-Liong Lin;Huang K.-T.;Lin R.-H.; Yen C.-J.; SHUEI-LIONG LIN; Huang K.-T.; Lin R.-H. |
| 臺大學術典藏 |
2021-01-12T03:32:35Z |
Effects of age and diabetes on blood flow rate and primary outcome of newly created hemodialysis arteriovenous fistulas
|
SHUEI-LIONG LIN; Huang C.-H.; Chen H.-S.; Hsu W.-A.; Yen C.-J.; Yen T.-S. |
| 臺大學術典藏 |
2021-01-12T03:32:23Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Lin Y.-F.; Chen Y.-M.; Hung K.-Y.; Chu T.-S.; Kan W.-C.; Huang C.-Y.; SHUEI-LIONG LIN; Kao T.-W.; Huang J.-W.; Chiang W.-C.; Yen C.-J.; Tsai T.-J.; Wu K.-D.; Wu M.-S. |
| 國立成功大學 |
2021 |
Comparing the clinicopathological characteristics of combined hepatocellular–cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification
|
Yen, C.-C.;Yen, C.-J.;Shan, Y.-S.;Lin, Y.-J.;Liu, I.-T.;Huang, Huang H.-Y.;Yeh, M.M.;Chan, S.-H.;Tsai, H.-W. |
| 國立成功大學 |
2021 |
No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol
|
Shan, Y.-S.;Chen, L.-T.;Wu, C.-H.;Chang, Y.-F.;Lee, C.-T.;Chiang, N.-J.;Chao, Y.-J.;Yen, C.-J.;Tsai, H.-J.;Huang, Huang H.-E.;Tsai, C.-R.;Weng, Y.-L.;Yang, H.-C.;Liu, H.-C.;Chang, J.S. |
| 國立成功大學 |
2021 |
Phase I Dose-Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid Tumors
|
Shiah, H.-S.;Chiang, N.-J.;Lin, C.-C.;Yen, C.-J.;Tsai, H.-J.;Wu, S.-Y.;Su, W.-C.;Chang, K.-Y.;Wang, C.-C.;Chang, J.-Y.;Chen, L.-T. |
| 國立成功大學 |
2021 |
Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2
|
Kudo, M.;Galle, P.R.;Brandi, G.;Kang, Y.-K.;Yen, C.-J.;Finn, R.S.;Llovet, J.M.;Assenat, E.;Merle, P.;Chan, S.L.;Palmer, D.H.;Ikeda, M.;Yamashita, T.;Vogel, A.;Huang, Y.-H.;Abada, P.B.;Yoshikawa, R.;Shinozaki, K.;Wang, C.;Widau, R.C.;Zhu, A.X. |
| 國立成功大學 |
2021 |
Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation
|
Lai, H.-Y.;Tsai, H.-H.;Yen, C.-J.;Hung, L.-Y.;Yang, C.-C.;Ho, C.-H.;Liang, H.-Y.;Chen, F.-W.;Li, C.-F.;Wang, J.-M. |
| 國立成功大學 |
2021 |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study
|
Chiu, T.-J.;Su, Y.-Y.;Yang, S.-H.;Li, C.-P.;Bai, L.-Y.;Chiang, N.-J.;Chuang, S.-C.;Shan, Y.-S.;Chan, D.-C.;Chen, L.-T.;Yen, C.-J.;Peng, C.-M.;Chen, Y.-Y.;Chen, J.-S.;Chou, W.-C. |
| 國立成功大學 |
2021 |
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma and elevated alpha-fetoprotein: Pooled results from two phase 3 studies (REACH and REACH-2)
|
Kudo, M.;Finn, R.S.;Morimoto, Morimoto M.;Rau, K.-M.;Ikeda, M.;Yen, C.-J.;Galle, P.R.;Llovet, J.M.;Daniele, B.;Lim, H.Y.;McIlwain, D.W.;Yoshikawa, R.;Nakamura, K.;Liang, K.;Wang, C.;Abada, P.;Widau, R.C.;Zhu, A.X. |
| 國立成功大學 |
2021 |
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression
|
Ryoo, B.-Y.;Cheng, A.-L.;Ren, Z.;Kim, T.-Y.;Pan, H.;Rau, K.-M.;Choi, H.J.;Park, J.-W.;Kim, J.H.;Yen, C.J.;Lim, H.Y.;Zhou, D.;Straub, J.;Scheele, J.;Berghoff, K.;Qin, S. |
| 國立成功大學 |
2021 |
The Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors – A Single-Center Experience
|
Tsai, H.-J.;Hsiao, C.-F.;Chang, J.S.;Chen, L.-T.;Chao, Y.-J.;Yen, C.-J.;Shan, Y.-S. |
| 國立成功大學 |
2021 |
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers
|
Chang, K.-Y.;Chiang, N.-J.;Wu, S.-Y.;Yen, C.-J.;Chen, S.-H.;Yeh, Yeh Y.-M.;Li, C.-F.;Feng, X.;Wu, K.;Johnston, A.;Bomalaski, J.S.;Wu, B.-W.;Gao, J.;Subudhi, Subudhi S.K.;Kaseb, A.O.;Blando, J.M.;Yadav, S.S.;Szlosarek, P.W.;Chen, L.-T. |
| 國立成功大學 |
2021 |
Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 study
|
Harding, J.J.;Yang, T.-S.;Chen, Y.-Y.;Feng, Y.-H.;Yen, C.-J.;Ho, C.-L.;Huang, W.-T.;El, Dika I.;Akce, M.;Tan, B.;Cohen, S.A.;Meyer, T.;Sarker, D.;Lee, D.-W.;Ryoo, B.-Y.;Lim, H.Y.;Johnston, A.;Bomalaski, J.S.;O’Reilly, E.M.;Qin, S.;Abou-Alfa, G.K. |
| 國立成功大學 |
2021 |
Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-na�ve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial
|
Adkins, D.R.;Lin, J.-C.;Sacco, A.;Ley, J.;Oppelt, P.;Vanchenko, Vanchenko V.;Komashko, N.;Yen, C.-J.;Wise-Draper, T.;Lopez-Picazo, Gonzalez J.;Radulovic, S.;Shen, Q.;Thurm, H.;Martini, J.-F.;Hoffman, J.;Huang, X.;Melichar, B.;Tahara, M. |
| 國立成功大學 |
2021 |
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
|
Even, C.;Wang, H.-M.;Li, S.-H.;Ngan, R.K.-C.;Dechaphunkul, A.;Zhang, L.;Yen, C.-J.;Chan, P.C.;Chakrabandhu, S.;Ma, B.B.Y.;Tanasanvimon, S.;Lee, V.H.F.;Lou, P.-J.;Li, Z.;Spira, A.I.;Sukari, A.;Guigay, J.;McCune, S.;Gonzalez-Maffe, J.;Szpakowski, Szpakowski S.;Yao, Yao Y.;Liang, H.;Mataraza, J.;Sechaud, R.;Manenti, L.;Lim, D.W.-T. |
| 國立成功大學 |
2021 |
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab
|
Zhu, A.X.;Finn, R.S.;Kang, Y.-K.;Yen, C.-J.;Galle, P.R.;Llovet, J.M.;Assenat, E.;Brandi, G.;Motomura, K.;Ohno, I.;Daniele, B.;Vogel, A.;Yamashita, T.;Hsu, C.-H.;Gerken, Gerken G.;Bilbruck, J.;Hsu, Y.;Liang, K.;Widau, R.C.;Wang, C.;Abada, P.;Kudo, M. |
| 國立成功大學 |
2021 |
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
|
Chao, J.;Fuchs, C.S.;Shitara, K.;Tabernero, J.;Muro, K.;Van, Cutsem E.;Bang, Y.-J.;De, Vita F.;Landers, G.;Yen, C.-J.;Chau, I.;Elme, A.;Lee, J.;Özgüroǧlu, M.;Catenacci, D.;Yoon, H.H.;Chen, E.;Adelberg, D.;Shih, C.-S.;Shah, Shah S.;Bhagia, P.;Wainberg, Z.A. |
| 國立成功大學 |
2021 |
Clinical and immunologic responses to a B-Cell epitope vaccine in patients with HER2/neu-overexpressing advanced gastric cancer—results from phase Ib trial IMU.ACS.001
|
Wiedermann, U.;Garner-Spitzer, E.;Chao, Y.;Maglakelidze, Maglakelidze M.;Bulat, I.;Dechaphunkul, A.;Arpornwirat, W.;Charoentum, Charoentum C.;Yen, C.-J.;Yau, T.C.;Tanasanvimon, S.;Maneechavakajorn, J.;Sookprasert, A.;Bai, L.-Y.;Chou, W.-C.;Ungtrakul, T.;Drinic, M.;Tobias, J.;Zielinski, C.C.;Chong, L.;Ede, N.J.;Marino, Marino M.T.;Good, A.J. |
| 國立成功大學 |
2021 |
Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
|
Mai, H.-Q.;Chen, Q.-Y.;Chen, D.;Hu, C.;Yang, K.;Wen, J.;Li, J.;Shi, Y.-R.;Jin, F.;Xu, R.;Pan, J.;Qu, S.;Li, P.;Hu, C.;Liu, Y.-C.;Jiang, Y.;He, X.;Wang, H.-M.;Lim, W.-T.;Liao, W.;He, X.;Chen, X.;Liu, Z.;Yuan, X.;Li, Q.;Lin, X.;Jing, S.;Chen, Y.;Lu, Y.;Hsieh, C.-Y.;Yang, M.-H.;Yen, C.-J.;Samol, J.;Feng, H.;Yao, S.;Keegan, P.;Xu, R.-H. |
| 臺大學術典藏 |
2020-12-28T12:04:16Z |
Metabolic risks, white matter hyperintensities, and arterial stiffness in high-functioning healthy adults
|
Kuo H.-K.; Chen C.-Y.; Liu H.-M.; Yen C.-J.; Chang K.-J.; Chang C.-C.; Yu Y.-H.; Lin L.-Y.; HWANG, JUEY-JEN |
| 臺大學術典藏 |
2020-12-28T01:53:09Z |
Nociceptive transient receptor potential canonical 7?(TRPC7) mediates aging-associated tumorigenesis induced by ultraviolet B
|
Hsu, W.-L.;Tsai, M.-H.;Wu, C.-Y.;Liang, J.-L.;Lu, J.-H.;Kahle, J.S.;Yu, H.-S.;Yen, C.-J.;Yen, C.-T.;Hsieh, Y.-C.;Huang, Y.-Y.;Lin, L.-C.;Tsai, T.-F.;Chen, C.-H.;Yoshioka, T.; Hsu, W.-L.; Tsai, M.-H.; Wu, C.-Y.; Liang, J.-L.; Lu, J.-H.; Kahle, J.S.; Yu, H.-S.; Yen, C.-J.; Yen, C.-T.; Hsieh, Y.-C.; Huang, Y.-Y.; Lin, L.-C.; Tsai, T.-F.; Chen, C.-H.; Yoshioka, T.; CHEN-TUNG YEN |
| 臺大學術典藏 |
2020-12-24T08:38:30Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Lin Y.-F.; Lin Y.-F.;Chen Y.-M.;Hung K.-Y.;Chu T.-S.;Kan W.-C.;Huang C.-Y.;Lin S.-L.;Kao T.-W.;Huang J.-W.;Wen-Chih Chiang;Yen C.-J.;Tsai T.-J.;Wu K.-D.;Wu M.-S.; Wu M.-S.; Wu K.-D.; Tsai T.-J.; Yen C.-J.; Chen Y.-M.; Hung K.-Y.; Chu T.-S.; Kan W.-C.; Huang C.-Y.; Lin S.-L.; Kao T.-W.; Huang J.-W.; WEN-CHIH CHIANG |
| 臺大學術典藏 |
2020-12-24T08:11:52Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
MING-SHIOU WU; Wu K.-D.; Tsai T.-J.; Chiang W.-C.; Yen C.-J.; Huang J.-W.; Kao T.-W.; Lin S.-L.; Huang C.-Y.; Kan W.-C.; Chu T.-S.; Hung K.-Y.; Chen Y.-M.; Lin Y.-F.; Lin Y.-F.;Chen Y.-M.;Hung K.-Y.;Chu T.-S.;Kan W.-C.;Huang C.-Y.;Lin S.-L.;Kao T.-W.;Huang J.-W.;Chiang W.-C.;Yen C.-J.;Tsai T.-J.;Wu K.-D.;Ming-Shiou Wu |
| 臺大學術典藏 |
2020-12-24T07:44:17Z |
Disintegrin modulates rat glomerular mesangial cell behavior
|
Chen C.-F.; Huang T.-F.; Yen C.-J.; Chen Y.-M.; Sheu J.-R.; TUN-JUN TSAI |
| 臺大學術典藏 |
2020-12-24T07:44:16Z |
Effect of intraperitoneally administered agents on human peritoneal mesothelial cell growth
|
Yen T.-S.; Lee P.-H.; Yang C.-C.; Fang C.-C.; Yen C.-J.; TUN-JUN TSAI |
| 臺大學術典藏 |
2020-12-24T07:44:16Z |
Continuous ambulatory peritoneal dialysis in the elderly: A seven-year experience
|
Yen C.-J.; TUN-JUN TSAI; Hsu W.-A.; Hung K.-Y.; Hou C.-H.; Yen T.-S. |
| 臺大學術典藏 |
2020-12-24T07:44:14Z |
Extracellular matrix proteins modulate human peritoneal mesothelial cell behavior
|
TUN-JUN TSAI; Lee P.-H.; Wu K.-D.; Lin R.-H.; Fang C.-C.; Chen Y.-M.; Yen C.-J. |
| 臺大學術典藏 |
2020-12-24T07:44:14Z |
Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients: Experience from Taiwan, an endemic area for hepatitis B
|
TUN-JUN TSAI; Wu K.-D.; Yen C.-J.; Lee K.-C.; Hung K.-Y.; Chen W.-Y. |
| 臺大學術典藏 |
2020-12-24T07:44:13Z |
Pharmacologic agents inhibit rat mesangial cell proliferation and collagen synthesis
|
Hsieh B.-S.; TUN-JUN TSAI; Fang C.-C.; Yen C.-J.; Shyu R.-S.; Wu M.-S. |
| 臺大學術典藏 |
2020-12-24T07:44:08Z |
Systemic lupus erythematosus and peritoneal dialysis: Outcomes and infectious complications
|
TUN-JUN TSAI; Wu K.-D.; Hung K.-Y.; Yen C.-J.; Huang J.-W. |
| 臺大學術典藏 |
2020-12-24T07:44:05Z |
Association between serum aspartate transaminase and homocysteine levels in hemodialysis patients
|
Huang J.-W.; Yen C.-J.; Pai M.-F.; Wu K.-D.; TUN-JUN TSAI; Hsieh B.-S. |
| 臺大學術典藏 |
2020-12-24T07:44:03Z |
Antibiotics induce apoptosis of human peritoneal mesothelial cells
|
Tomino Y.; Fang C.-C.; Yen C.-J.; TUN-JUN TSAI; Chen R.-H.; Lee P.-H. |
| 臺大學術典藏 |
2020-12-24T07:43:48Z |
Hyperuricemia Associated With Rapid Renal Function Decline in Elderly Taiwanese Subjects
|
Wu K.-D.; TUN-JUN TSAI; Hung K.-Y.; Hsu S.H.-J.; Ho L.-C.; Chiang C.-K.; Yen C.-J. |
| 臺大學術典藏 |
2020-12-24T07:43:47Z |
Life expectancy, expected years of life lost and survival of hemodialysis and peritoneal dialysis patients
|
Kao T.-W.; Huang J.-W.; Hung K.-Y.; Chang Y.-Y.; Chen P.-C.; Yen C.-J.; Chen Y.-M.; Chu T.-S.; Wu M.-S.; TUN-JUN TSAI; Wu K.-D.; Wang J.-D. |
| 臺大學術典藏 |
2020-12-24T07:43:47Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Wu K.-D.; Wu M.-S.; TUN-JUN TSAI; Yen C.-J.; Chiang W.-C.; Huang J.-W.; Kao T.-W.; Lin S.-L.; Huang C.-Y.; Kan W.-C.; Chu T.-S.; Hung K.-Y.; Chen Y.-M.; Lin Y.-F. |
| 臺大學術典藏 |
2020-12-24T07:43:45Z |
Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis
|
Huang J.-W.; Yen C.-J.; Wu H.-Y.; Chiang C.-K.; Cheng H.-T.; Lien Y.-C.; Hung K.-Y.; TUN-JUN TSAI |
| 臺大學術典藏 |
2020-12-24T07:01:47Z |
Systemic lupus erythematosus and peritoneal dialysis: Outcomes and infectious complications
|
Jenq-Wen Huang;Hung K.-Y.;Yen C.-J.;Wu K.-D.;Tsai T.-J.; JENQ-WEN HUANG; Hung K.-Y.; Yen C.-J.; Wu K.-D.; Tsai T.-J. |
| 臺大學術典藏 |
2020-12-24T07:01:47Z |
Incidence of exit-site infection with various exchange systems in continuous ambulatory peritoneal dialysis
|
Jenq-Wen Huang;Hung K.-Y.;Wu K.-D.;Yen C.-J.;Tsai T.-J.;Hsieh B.-S.; JENQ-WEN HUANG; Hung K.-Y.; Wu K.-D.; Yen C.-J.; Tsai T.-J.; Hsieh B.-S. |
| 臺大學術典藏 |
2020-12-24T07:01:46Z |
Association between serum aspartate transaminase and homocysteine levels in hemodialysis patients
|
Jenq-Wen Huang;Yen C.-J.;Pai M.-F.;Wu K.-D.;Tsai T.-J.;Hsieh B.-S.; JENQ-WEN HUANG; Yen C.-J.; Pai M.-F.; Wu K.-D.; Tsai T.-J.; Hsieh B.-S. |
| 臺大學術典藏 |
2020-12-24T07:01:46Z |
Comparison of infectious complications in peritoneal dialysis patients using either a twin-bag system or automated peritoneal dialysis
|
Jenq-Wen Huang;Hung K.-Y.;Yen C.-J.;Wu K.-D.;Tsai T.-J.; JENQ-WEN HUANG; Hung K.-Y.; Yen C.-J.; Wu K.-D.; Tsai T.-J. |
| 臺大學術典藏 |
2020-12-24T07:01:45Z |
Adiponectin in peritoneal dialysis patients: A comparison with hemodialysis patients and subjects with normal renal function
|
Jenq-Wen Huang;Yen C.-J.;Chiang H.-W.;Hung K.-Y.;Tsai T.-J.;Wu K.-D.; JENQ-WEN HUANG; Yen C.-J.; Chiang H.-W.; Hung K.-Y.; Tsai T.-J.; Wu K.-D. |
| 臺大學術典藏 |
2020-12-24T07:01:36Z |
Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis
|
Wu H.-Y.; Yen C.-J.; JENQ-WEN HUANG; Jenq-Wen Huang ;Yen C.-J. ;Wu H.-Y. ;Chiang C.-K. ;Cheng H.-T. ;Lien Y.-C. ;Hung K.-Y. ;Tsai T.-J.; Chiang C.-K.; Cheng H.-T.; Lien Y.-C.; Hung K.-Y.; Tsai T.-J. |
| 臺大學術典藏 |
2020-12-24T07:01:36Z |
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
|
Wu M.-S.; Wu K.-D.; Tsai T.-J.; Chiang W.-C.; Yen C.-J.; JENQ-WEN HUANG; Kao T.-W.; Lin S.-L.; Huang C.-Y.; Kan W.-C.; Chu T.-S.; Hung K.-Y.; Chen Y.-M.; Lin Y.-F.; Lin Y.-F.;Chen Y.-M.;Hung K.-Y.;Chu T.-S.;Kan W.-C.;Huang C.-Y.;Lin S.-L.;Kao T.-W.;Jenq-Wen Huang;Chiang W.-C.;Yen C.-J.;Tsai T.-J.;Wu K.-D.;Wu M.-S. |
| 臺大學術典藏 |
2020-12-24T07:01:36Z |
Life expectancy, expected years of life lost and survival of hemodialysis and peritoneal dialysis patients
|
Wang J.-D.; Wu K.-D.; Kao T.-W.;Jenq-Wen Huang;Hung K.-Y.;Chang Y.-Y.;Chen P.-C.;Yen C.-J.;Chen Y.-M.;Chu T.-S.;Wu M.-S.;Tsai T.-J.;Wu K.-D.;Wang J.-D.; Kao T.-W.; JENQ-WEN HUANG; Hung K.-Y.; Chang Y.-Y.; Chen P.-C.; Yen C.-J.; Chen Y.-M.; Chu T.-S.; Wu M.-S.; Tsai T.-J. |
| 臺大學術典藏 |
2020-12-24T07:01:34Z |
Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly
|
Cheng H.-T.;Jenq-Wen Huang;Chiang C.-K.;Yen C.-J.;Hung K.-Y.;Wu K.-D.; Cheng H.-T.; JENQ-WEN HUANG; Chiang C.-K.; Yen C.-J.; Hung K.-Y.; Wu K.-D. |
| 臺大學術典藏 |
2020-12-24T07:01:33Z |
Fibrin-Induced Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelial Cells as a Mechanism of Peritoneal Fibrosis: Effects of Pentoxifylline
|
Fang C.-C.; JENQ-WEN HUANG; Shyu R.-S.; Yen C.-J.; Shiao C.-H.; Chiang C.-K.; Hu R.-H.; Tsai T.-J. |
| 臺大學術典藏 |
2020-12-24T07:01:32Z |
High peritoneal KT/V and peritonitis rates are associated with peritoneal calcification.
|
Yen C.J.; Cheng H.T.; Chiang C.K.; Wu H.Y.; Lee J.K.; Wu C.K.; Fang C.C.; Liu K.L.; JENQ-WEN HUANG; Lien Y.C.; Yang C.Y.; Hung K.Y. |
| 臺大學術典藏 |
2020-12-24T07:01:31Z |
Glycosylated Hemoglobin and Albumin-Corrected Fructosamine Are Good Indicators for Glycemic Control in Peritoneal Dialysis Patients
|
Lee S.-Y.; Chen Y.-C.; Tsai I.-C.; Yen C.-J.; Chueh S.-N.; Chuang H.-F.; Wu H.-Y.; Chiang C.-K.; Cheng H.-T.; Hung K.-Y.; JENQ-WEN HUANG |
Showing items 181-230 of 471 (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
|
